AIT Therapeutics’ Adjuvant Nitric Oxide Treatment Shown to be Safe and Effective in the Compassionate Use Setting in Cystic Fibrosis Patients with Non-tuberculous Mycobacteria (NTM) Infection

World News: . []

REHOVOT Israel and NEW YORK Sept 13 2017 GLOBE NEWSWIRE) -- AIT Therapeutics Inc OTCAITB a clinical-stage anti-microbial therapeutic company treating respiratory diseases with nitric oxide NO today announced publication of a manuscrip t of it...

More news and information about AIT Therapeutics, Inc.

Published By:

Globe Newswire: 13:30 GMT Wednesday 13th September 2017

Published: .

Search for other references to "therapeutics" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers